(March 18 05:17) World.einnews.com
… -stage biotechnology company commercializing a novel vaccination platform, today announced the … commercial potential of Vaxxas' novel high-density microarray patch (HD … and tolerability of A/Singapore/;GP1908/2015 H1N1 …
You can find the original article
here